Ardelyx | ARDX - Pre Tax Profit

Stock Price
6.10
Daily Change
-0.01 -0.16%
Monthly
-3.17%
Yearly
45.93%
Q2 Forecast
6.10

Ardelyx reported $-400K in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Amgen USD 1.51B 2.41B Dec/2025
Ardelyx USD -400K 467K Dec/2025
aTyr Pharma USD -25.75M 6.22M Sep/2025
Corcept Therapeutics USD 9.91M 5.33M Dec/2025
Curis USD 19.36M 33.34M Dec/2025
Sanofi EUR -1.16B 6.23B Dec/2025
TG Therapeutics USD 20.36M 24.73M Mar/2026
United Therapeutics USD 444M 6M Dec/2025
Xoma USD 15.98M 24.58M Jun/2024